Skip to main content

Table 3 Resource utilisation among patients with AGC during follow-up

From: The economic burden of advanced gastric cancer in Taiwan

Resource utilisation n Total (n = 118) BSC (n = 40) 2nd-line TX (n = 78)
Mean follow-up days (SD) 118 397.1 (300.0)
[Median: 291.5]
296.9 (228.6)
[Median: 211.5]
448.5 (320.0)
[Median: 326.5]
Inpatient stay (days), mean(SD)
 Overnight inpatient stay 118 19.6 (22.5) 17.9 (26.0) 20.5 (20.6)
 Hospice unit stay 99 2.4 (5.1) 2.0 (3.2) 2.6 (5.9)
 Skilled nursing facility stay 96 2.4 (20.4) 7.2 (36.4) 0.2 (1.1)
 Oncology-oriented inpatient a rehabilitation clinic stay a 96 7.5 (18.0) 12.5 (25.1) 5.2 (13.3)
Total 94 29.0 (37.3) 34.8 (52.2) 26.4 (28.4)
Outpatient visits (visits), mean(SD)
 Outpatient clinic visits 86 19.6 (14.0) 19.1 (16.9) 19.8 (13.0)
 Nutritional support visits 104 1.3 (2.2) 1.4 (1.4) 1.3 (2.5)
 Home visits 97 0.7 (1.8) 0.7 (1.0) 0.7 (2.1)
Total 84 21.1 (15.4) 19.9 (17.6) 21.4 (14.7)
  1. Abbreviations: AGC Advanced Gastric Cancer, BSC Best Supportive Care, SD Standard Deviation, TX treatment
  2. aBoth parametric and non-parametric tests indicated no statistically significant differences in resource utilisation between patients with BSC and patients with second-line treatment following the first-line treatment, except for skilled nursing facility stay (Mann-Whitney test p-value = 0.019). [Also in oncology-oriented inpatient rehabilitation clinic visits at p < 0.1 (t-test p-value = 0.066, Mann-Whitney p-value = 0.061)